Androgen receptor expression and breast cancer survival in postmenopausal women R Hu, S Dawood, MD Holmes, LC Collins, SJ Schnitt, K Cole, JD Marotti, ... Clinical cancer research 17 (7), 1867-1874, 2011 | 488 | 2011 |
Comparison of molecular phenotypes of ductal carcinoma in situand invasive breast cancer RM Tamimi, HJ Baer, J Marotti, M Galan, L Galaburda, Y Fu, AC Deitz, ... Breast Cancer Research 10, 1-9, 2008 | 415 | 2008 |
Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study LC Collins, KS Cole, JD Marotti, R Hu, SJ Schnitt, RM Tamimi Modern Pathology 24 (7), 924-931, 2011 | 405 | 2011 |
Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer RM Tamimi, GA Colditz, A Hazra, HJ Baer, SE Hankinson, B Rosner, ... Breast cancer research and treatment 131, 159-167, 2012 | 282 | 2012 |
Critical evaluation of frozen section margins in head and neck cancer resections C Black, J Marotti, E Zarovnaya, J Paydarfar Cancer 107 (12), 2792-2800, 2006 | 139 | 2006 |
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity S Chiang, B Weigelt, HC Wen, F Pareja, A Raghavendra, LG Martelotto, ... Cancer research 76 (24), 7118-7129, 2016 | 119 | 2016 |
Triple-negative breast cancer: next-generation sequencing for target identification JD Marotti, FB de Abreu, WA Wells, GJ Tsongalis The American journal of pathology 187 (10), 2133-2138, 2017 | 95 | 2017 |
Implementation of a molecular tumor board: the impact on treatment decisions for 35 patients evaluated at Dartmouth-Hitchcock Medical Center LJ Tafe, IP Gorlov, FB De Abreu, JA Lefferts, X Liu, JR Pettus, JD Marotti, ... The oncologist 20 (9), 1011-1018, 2015 | 91 | 2015 |
Comparison of estrogen receptor results from pathology reports with results from central laboratory testing LC Collins, JD Marotti, HJ Baer, RM Tamimi JNCI: Journal of the National Cancer Institute 100 (3), 218-221, 2008 | 77 | 2008 |
DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer KC Johnson, DC Koestler, T Fleischer, P Chen, EG Jenson, JD Marotti, ... Clinical epigenetics 7, 1-12, 2015 | 70 | 2015 |
Impact of the 2013 ASCO/CAP HER2 Guideline Updates at an Academic Medical Center That Performs Primary HER2 FISH Testing: Increase in Equivocal Results … KE Muller, JD Marotti, VA Memoli, WA Wells, LJ Tafe American journal of clinical pathology 144 (2), 247-252, 2015 | 62 | 2015 |
Implementation of telecytology for immediate assessment of endoscopic ultrasound-guided fine-needle aspirations compared to conventional on-site evaluation: analysis of 240 … JD Marotti, V Johncox, D Ng, JL Gonzalez, V Padmanabhan Acta cytologica 56 (5), 548-553, 2012 | 56 | 2012 |
A patient-specific 3D-printed form accurately transfers supine MRI-derived tumor localization information to guide breast-conserving surgery RJ Barth, V Krishnaswamy, KD Paulsen, TB Rooney, WA Wells, E Rizzo, ... Annals of surgical oncology 24, 2950-2956, 2017 | 40 | 2017 |
Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancers KE Muller, JD Marotti, FB de Abreu, JD Peterson, TW Miller, ... Experimental and molecular pathology 100 (3), 421-425, 2016 | 33 | 2016 |
Molecular phenotype of breast cancer according to time since last pregnancy in a large cohort of young women LC Collins, S Gelber, JD Marotti, S White, K Ruddy, EF Brachtel, ... The oncologist 20 (7), 713-718, 2015 | 24 | 2015 |
Cytomorphologic features of advanced lung adenocarcinomas tested for EGFR and KRAS mutations: a retrospective review of 50 cases JD Marotti, MC Schwab, NJ McNulty, JR Rigas, PA DeLong, VA Memoli, ... Diagnostic cytopathology 41 (1), 15-21, 2013 | 23 | 2013 |
Gastroenteropancreatic neuroendocrine tumors in patients with HIV infection: a trans-Atlantic series P Lito, J Marotti, BJ Dezube, L Pantanowitz, DM Aboulafia, V Campbell, ... The American journal of the medical sciences 337 (1), 1-4, 2009 | 23 | 2009 |
Pathologic Features and Clinical Implications of Breast Cancer With HER2 Intratumoral Genetic Heterogeneity: An Institutional Review KE Muller, JD Marotti, LJ Tafe American Journal of Clinical Pathology 152 (1), 7-16, 2019 | 22 | 2019 |
Estrogen receptor alpha drives mTORC1 inhibitor-induced feedback activation of PI3K/AKT in ER+ breast cancer W Yang, GN Schwartz, JD Marotti, V Chen, NA Traphagen, J Gui, ... Oncotarget 9 (10), 8810, 2018 | 21 | 2018 |
Clinical genotyping of non–small cell lung cancers using targeted next-generation sequencing: utility of identifying rare and co-mutations in oncogenic driver genes LJ Tafe, KJ Pierce, JD Peterson, F de Abreu, VA Memoli, CC Black, ... Neoplasia 18 (9), 577-583, 2016 | 21 | 2016 |